Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
Stock data | 2024 | Change |
---|---|---|
Price | $0.0022 | N/A |
Market Cap | $1.83K | N/A |
Shares Outstanding | 832.02K | N/A |
Employees | 5.00 | N/A |